Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells. (Q38342295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1

Rumiana Bakalova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Hideki Ohba

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Zhivko Zhelev

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Masayuki Fujii

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Mitsuru Ishikawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Yasuo Shinohara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Yoshinobu Baba

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

564

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

73-84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

Studying the pathogenesis of BCR-ABL+ leukemia in mice

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Recent advancements in the treatment of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Protein kinases as targets for anticancer agents: from inhibitors to useful drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Telomeres and telomerase in hematologic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

The RNA component of human telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Protein kinase Ciota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Telomerase is controlled by protein kinase Calpha in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Telomere length measurement by fluorescence in situ hybridization and flow cytometry: tips and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Telomere length measurements in leukocyte subsets by automated multicolor flow-FISH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Inhibition of human telomerase activity by peptide nucleic acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Antisense technologies. Improvement through novel chemical modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

TRF1 is a dimer and bends telomeric DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

POT1 as a terminal transducer of TRF1 telomere length control

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Tankyrase, a poly(ADP-ribose) polymerase at human telomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Tankyrase promotes telomere elongation in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

Peptide nucleic acids and their potential applications in biotechnology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2804%2900318-7

10.1016/S0014-5793(04)00318-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15094045%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference